Anthony Principi
CIK 1347187 · last filed 2020-09-30
Anthony Principi is a corporate insider who has filed 26 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for HROW, was dated Sep 30, 2020. Current disclosed insider exposure totals $2.7M across reported positions. 8 SEC filings were submitted jointly with HARROW HEALTH, INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EGL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PLANO, TX 75244
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HROW | Director | 93,798 | $29.24 | $2.74M | $0 | 3 | 2020-09-30 |
| Engility Holdings, Inc. (EGL) Delisted | Director | 14,075 | — | — | $0 | 10 | 2019-01-14 |
| HARROW, INC. (IMMY) Delisted | Director | 4,573 | — | — | $0 | 4 | 2018-07-02 |
| Statera Biopharma, Inc. (CBLI) Delisted | Director | 2,621 | $3.17 | $8.3K | $0 | 5 | 2015-04-24 |
| PEROT SYSTEMS CORP (PER) Delisted | Director | 20,000 | — | — | $0 | 3 | 2009-06-02 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-09-30 | HROW | Exer (M) | +93,798 | $0 | EDGAR |
| 2020-06-08 | HROW | Grant (A) | — | $0 | EDGAR |
| 2019-06-28 | HROW | Grant (A) | — | $0 | EDGAR |
| 2019-01-14 | Engility Holdings, Inc. (EGL) Delisted | Exer (M) | +8,432 | $0 | EDGAR |
| 2019-01-14 | Engility Holdings, Inc. (EGL) Delisted | Disp (D) | −18,536 | $0 | EDGAR |
| 2018-07-02 | HARROW, INC. (IMMY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-29 | Engility Holdings, Inc. (EGL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-09 | Engility Holdings, Inc. (EGL) Delisted | Grant (A) | +814 | $0 | EDGAR |
| 2017-06-15 | HARROW, INC. (IMMY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-30 | Engility Holdings, Inc. (EGL) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.